| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 PKNOX1 REL ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 APP ZBTB11 ZNF442 NR1D1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 1.33e-26 | 1459 | 77 | 41 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 PKNOX1 REL ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 NR1D1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 5.61e-26 | 1412 | 77 | 40 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF490 BCL6B ZNF131 ZNF18 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF48 ZNF792 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 PKNOX1 REL ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 APP ZBTB11 NR1D1 ZNF768 ZNF786 ZNF572 ZNF513 | 5.99e-17 | 1244 | 77 | 30 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF490 BCL6B ZNF131 ZNF18 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF48 ZNF792 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 PKNOX1 REL ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 APP ZBTB11 NR1D1 ZNF768 ZNF786 ZNF572 ZNF513 | 1.08e-16 | 1271 | 77 | 30 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF131 ZNF836 ZNF48 GLI2 ZNF780B ZNF629 REL ZSCAN2 ZNF841 ZNF786 | 5.64e-05 | 560 | 77 | 10 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF131 ZNF836 ZNF48 GLI2 ZNF780B ZNF629 REL ZSCAN2 ZNF841 ZNF786 | 6.16e-05 | 566 | 77 | 10 | GO:0001216 |
| GeneOntologyMolecularFunction | TAP complex binding | 5.19e-04 | 9 | 77 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 5.19e-04 | 9 | 77 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 6.47e-04 | 10 | 77 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 6.47e-04 | 10 | 77 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 6.47e-04 | 10 | 77 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 9.45e-04 | 12 | 77 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.48e-03 | 320 | 77 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | RAGE receptor binding | 1.49e-03 | 15 | 77 | 2 | GO:0050786 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.62e-03 | 326 | 77 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.92e-03 | 17 | 77 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.67e-03 | 20 | 77 | 2 | GO:0042608 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF131 ZNF836 ZNF142 OGT ZNF48 TCF20 GLI2 ZMIZ2 MAZ ZNF780B ZNF629 PKNOX1 HMGB1 REL ZNF841 APP NR1D1 ZNF786 ZNF513 | 4.64e-07 | 1390 | 76 | 19 | GO:0045944 |
| Domain | - | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 7.06e-35 | 679 | 75 | 38 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 1.52e-34 | 693 | 75 | 38 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 1.61e-34 | 694 | 75 | 38 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF474 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 3.95e-34 | 775 | 75 | 39 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF474 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 4.37e-34 | 777 | 75 | 39 | PS00028 |
| Domain | Znf_C2H2 | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF474 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 1.70e-33 | 805 | 75 | 39 | IPR007087 |
| Domain | Znf_C2H2-like | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 2.75e-32 | 796 | 75 | 38 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 4.80e-32 | 808 | 75 | 38 | SM00355 |
| Domain | zf-C2H2_6 | ZNF490 ZNF10 ZNF627 ZSCAN5B ZNF836 ZNF182 ZNF672 ZNF48 ZNF555 ZNF792 ZNF425 ZNF780B ZNF500 ZNF69 ZSCAN2 ZNF841 ZBTB11 ZNF442 ZNF169 ZNF572 | 6.19e-19 | 314 | 75 | 20 | PF13912 |
| Domain | KRAB | ZNF490 ZNF10 ZNF18 ZNF627 ZNF836 ZNF182 ZNF555 ZNF792 ZNF425 ZNF780B ZNF500 ZNF69 ZNF350 ZNF81 ZNF772 ZNF442 ZNF786 ZNF169 ZNF557 | 1.57e-16 | 358 | 75 | 19 | PS50805 |
| Domain | KRAB | ZNF490 ZNF10 ZNF18 ZNF627 ZNF836 ZNF182 ZNF555 ZNF792 ZNF425 ZNF780B ZNF500 ZNF69 ZNF350 ZNF81 ZNF772 ZNF442 ZNF786 ZNF169 ZNF557 | 1.57e-16 | 358 | 75 | 19 | PF01352 |
| Domain | KRAB | ZNF490 ZNF10 ZNF18 ZNF627 ZNF836 ZNF182 ZNF555 ZNF792 ZNF425 ZNF780B ZNF500 ZNF69 ZNF350 ZNF81 ZNF772 ZNF442 ZNF786 ZNF169 ZNF557 | 2.74e-16 | 369 | 75 | 19 | SM00349 |
| Domain | KRAB | ZNF490 ZNF10 ZNF18 ZNF627 ZNF836 ZNF182 ZNF555 ZNF792 ZNF425 ZNF780B ZNF500 ZNF69 ZNF350 ZNF81 ZNF772 ZNF442 ZNF786 ZNF169 ZNF557 | 2.88e-16 | 370 | 75 | 19 | IPR001909 |
| Domain | SCAN | 7.52e-05 | 56 | 75 | 4 | SM00431 | |
| Domain | SCAN_BOX | 8.63e-05 | 58 | 75 | 4 | PS50804 | |
| Domain | SCAN | 8.63e-05 | 58 | 75 | 4 | PF02023 | |
| Domain | SCAN_dom | 8.63e-05 | 58 | 75 | 4 | IPR003309 | |
| Domain | Retrov_capsid_C | 9.23e-05 | 59 | 75 | 4 | IPR008916 | |
| Domain | FAM86 | 9.50e-05 | 4 | 75 | 2 | PF14904 | |
| Domain | FAM86 | 9.50e-05 | 4 | 75 | 2 | IPR029426 | |
| Domain | C2H2_Znf_fam | 1.18e-04 | 24 | 75 | 3 | IPR027775 | |
| Domain | MHC_I_C | 2.36e-04 | 6 | 75 | 2 | PF06623 | |
| Domain | MHC_I_a_C | 2.36e-04 | 6 | 75 | 2 | IPR010579 | |
| Domain | Methyltransf_16 | 8.55e-04 | 11 | 75 | 2 | IPR019410 | |
| Domain | Methyltransf_16 | 8.55e-04 | 11 | 75 | 2 | PF10294 | |
| Domain | Kringle | 2.08e-03 | 17 | 75 | 2 | IPR000001 | |
| Domain | Kringle | 2.08e-03 | 17 | 75 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 2.08e-03 | 17 | 75 | 2 | PS00021 | |
| Domain | Kringle_CS | 2.08e-03 | 17 | 75 | 2 | IPR018056 | |
| Domain | KR | 2.08e-03 | 17 | 75 | 2 | SM00130 | |
| Domain | KRINGLE_2 | 2.08e-03 | 17 | 75 | 2 | PS50070 | |
| Domain | MHC_I | 3.18e-03 | 21 | 75 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 3.18e-03 | 21 | 75 | 2 | IPR001039 | |
| Domain | - | 4.15e-03 | 24 | 75 | 2 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 4.15e-03 | 24 | 75 | 2 | IPR011161 | |
| Domain | Kringle-like | 7.30e-03 | 32 | 75 | 2 | IPR013806 | |
| Domain | MHC_I/II-like_Ag-recog | 1.02e-02 | 38 | 75 | 2 | IPR011162 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF490 ZNF10 ZNF18 ZNF627 ZNF555 ZNF792 ZNF425 GLI2 ZNF500 ZNF350 ZNF772 ZNF442 NR1D1 ZNF786 ZNF169 ZNF557 | 1.36e-05 | 1387 | 50 | 16 | M734 |
| Pathway | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | 1.22e-04 | 5 | 50 | 2 | MM15475 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.83e-04 | 6 | 50 | 2 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.56e-04 | 7 | 50 | 2 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.56e-04 | 7 | 50 | 2 | M47530 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.37e-04 | 9 | 50 | 2 | MM14527 | |
| Pubmed | 1.63e-07 | 181 | 77 | 7 | 37372979 | ||
| Pubmed | ZNF131 ZNF18 ZSCAN5B ZNF836 ZNF48 TCF20 ZMIZ2 PKNOX1 HMGB1 NR1D1 ZNF786 ZNF513 | 2.10e-07 | 808 | 77 | 12 | 20412781 | |
| Pubmed | FAM86B1 ZNF18 ZNF836 OGT HLA-A HLA-B PKNOX1 ZNF350 ZNF841 APP SNRNP70 ZBTB11 NR1D1 ATP2A2 | 7.86e-07 | 1285 | 77 | 14 | 35914814 | |
| Pubmed | Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. | 8.68e-07 | 9 | 77 | 3 | 17446933 | |
| Pubmed | ZNF131 ZNF536 OGT TCF20 GLI2 ZMIZ2 MAZ XRN1 ZNF629 HMGB1 REL SNRNP70 ATP2A2 ZNF768 | 2.73e-06 | 1429 | 77 | 14 | 35140242 | |
| Pubmed | 3.73e-06 | 14 | 77 | 3 | 2014798 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 14601650 | ||
| Pubmed | Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. | 4.84e-06 | 2 | 77 | 2 | 20032191 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11752149 | ||
| Pubmed | Association of HLA genotypes with phenobarbital hypersensitivity in children. | 4.84e-06 | 2 | 77 | 2 | 27554620 | |
| Pubmed | HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia. | 4.84e-06 | 2 | 77 | 2 | 24084328 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15362660 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26083016 | ||
| Pubmed | HLA A*02 allele frequencies and B haplotype associations in Western Indians. | 4.84e-06 | 2 | 77 | 2 | 12691707 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26375851 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26613657 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24389314 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11485622 | ||
| Pubmed | [Polymorphism research on the distribution of four HLA alleles in five Chinese populations]. | 4.84e-06 | 2 | 77 | 2 | 16120569 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11862383 | ||
| Pubmed | [Analysis of HPA1-16 and HLA-A, B gene polymorphisms among ethnic Han population from Shandong]. | 4.84e-06 | 2 | 77 | 2 | 27577225 | |
| Pubmed | The association and linkage of the HLA-A2 class I allele with autism. | 4.84e-06 | 2 | 77 | 2 | 16720216 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15611225 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19727231 | ||
| Pubmed | Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo. | 4.84e-06 | 2 | 77 | 2 | 19091857 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9971776 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33391255 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12956877 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28383785 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25243920 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19392852 | ||
| Pubmed | Possible role of deep tubular invaginations of the plasma membrane in MHC-I trafficking. | 4.84e-06 | 2 | 77 | 2 | 15878340 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26057149 | ||
| Pubmed | Somatic mutations in the HLA genes of patients with hematological malignancy. | 4.84e-06 | 2 | 77 | 2 | 22489945 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12437654 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 34523962 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28661939 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 14989713 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12366789 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12366790 | ||
| Pubmed | [Influence of HLA-A, B loci carrying Bw4 motif on HIV CD4 T cell count and viral load]. | 4.84e-06 | 2 | 77 | 2 | 21029668 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18344933 | ||
| Pubmed | Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. | 4.84e-06 | 2 | 77 | 2 | 18004301 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19536817 | ||
| Pubmed | HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection. | 4.84e-06 | 2 | 77 | 2 | 24737799 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10403641 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17609824 | ||
| Pubmed | HLA-A and HLA-B gene polymorphism and idiopathic pulmonary fibrosis in a Han Chinese population. | 4.84e-06 | 2 | 77 | 2 | 22784404 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25099678 | ||
| Pubmed | Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. | 4.84e-06 | 2 | 77 | 2 | 12029127 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19683024 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9714480 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20650849 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 32439725 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 14969772 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11260507 | ||
| Pubmed | HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis. | 4.84e-06 | 2 | 77 | 2 | 24336023 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15140031 | ||
| Pubmed | Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. | 4.84e-06 | 2 | 77 | 2 | 20072141 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28185422 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33441319 | ||
| Pubmed | HLA-A and -B Type and Haplotype Frequencies in IgG Subclass Deficiency Subgroups. | 4.84e-06 | 2 | 77 | 2 | 32307610 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 1589035 | ||
| Pubmed | HLA class I haplotypes in families of children with coeliac disease. | 4.84e-06 | 2 | 77 | 2 | 11208333 | |
| Pubmed | Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. | 4.84e-06 | 2 | 77 | 2 | 21963603 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18971283 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15070694 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17429413 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17610418 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 72068 | ||
| Pubmed | Origins and relatedness of human leukocyte antigen class I allele supertypes. | 4.84e-06 | 2 | 77 | 2 | 20600449 | |
| Pubmed | Identification of three novel HLA class I alleles: HLA-A*0261, HLA-B*1585 and HLA-B*1587. | 4.84e-06 | 2 | 77 | 2 | 15853906 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16671946 | ||
| Pubmed | Differential association between HLA and diffuse panbronchiolitis in Northern and Southern Chinese. | 4.84e-06 | 2 | 77 | 2 | 22293801 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11602047 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19803716 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25775543 | ||
| Pubmed | HLA-A and HLA-B distribution in Toto - a vanishing sub-Himalayan tribe of India. | 4.84e-06 | 2 | 77 | 2 | 16451204 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22925811 | ||
| Pubmed | [Human leukocyte antigens A and B in Turkish patients with sarcoidosis]. | 4.84e-06 | 2 | 77 | 2 | 15491536 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23061377 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24324503 | ||
| Pubmed | Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences. | 4.84e-06 | 2 | 77 | 2 | 26787826 | |
| Pubmed | HLA class I typing in Egyptian childhood minimal change nephrotic syndrome. | 4.84e-06 | 2 | 77 | 2 | 18949728 | |
| Pubmed | Detection of two novel alleles, HLA-A*02:943 and -B*51:104:02, in Greek cord blood units. | 4.84e-06 | 2 | 77 | 2 | 33191636 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18190553 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15793795 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 27067905 | ||
| Pubmed | Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study. | 4.84e-06 | 2 | 77 | 2 | 37895076 | |
| Pubmed | Study of HLA Class I gene in Indian schizophrenic patients of Siliguri, West Bengal. | 4.84e-06 | 2 | 77 | 2 | 21459456 | |
| Pubmed | Activation of complement and contact system in Alzheimer's disease. | 4.84e-06 | 2 | 77 | 2 | 11589915 | |
| Pubmed | HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. | 4.84e-06 | 2 | 77 | 2 | 12826378 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23349864 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29350020 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11285128 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12803653 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12502873 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16305683 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25187890 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25355886 | ||
| Interaction | KRTAP10-7 interactions | ZNF490 BCL6B ZNF555 ZNF792 ZNF425 ZNF837 APP ZNF786 ZNF169 ZNF491 ZNF572 | 1.45e-08 | 293 | 77 | 11 | int:KRTAP10-7 |
| Interaction | CCNDBP1 interactions | 5.27e-08 | 137 | 77 | 8 | int:CCNDBP1 | |
| Interaction | NOTCH2 interactions | ZNF490 ZNF627 ZNF142 ZNF672 ZNF48 ZNF555 MAZ ZNF629 ZSCAN2 ATP2A2 REPIN1 ZNF768 | 6.71e-08 | 423 | 77 | 12 | int:NOTCH2 |
| Interaction | CPNE7 interactions | 7.10e-07 | 82 | 77 | 6 | int:CPNE7 | |
| Interaction | LTBP2 interactions | 8.78e-07 | 85 | 77 | 6 | int:LTBP2 | |
| Interaction | ZNF473 interactions | 2.34e-06 | 56 | 77 | 5 | int:ZNF473 | |
| Interaction | ZNF835 interactions | 6.63e-06 | 69 | 77 | 5 | int:ZNF835 | |
| Interaction | TCP11L1 interactions | 1.00e-05 | 75 | 77 | 5 | int:TCP11L1 | |
| Interaction | ZKSCAN8 interactions | 1.05e-05 | 130 | 77 | 6 | int:ZKSCAN8 | |
| Interaction | GOLGA6L9 interactions | 1.88e-05 | 216 | 77 | 7 | int:GOLGA6L9 | |
| Interaction | TRIM41 interactions | 2.30e-05 | 223 | 77 | 7 | int:TRIM41 | |
| Interaction | CIART interactions | 2.36e-05 | 15 | 77 | 3 | int:CIART | |
| Interaction | KRTAP2-3 interactions | 3.16e-05 | 95 | 77 | 5 | int:KRTAP2-3 | |
| Interaction | KRTAP10-9 interactions | 3.78e-05 | 241 | 77 | 7 | int:KRTAP10-9 | |
| Interaction | RPLP0 interactions | OGT ZNF48 XRN1 RNF8 ZNF629 HMGB1 APP SNRNP70 ZBTB11 REPIN1 ZNF768 | 4.01e-05 | 660 | 77 | 11 | int:RPLP0 |
| Interaction | KRTAP2-4 interactions | 4.25e-05 | 101 | 77 | 5 | int:KRTAP2-4 | |
| Interaction | ZNF330 interactions | 5.00e-05 | 446 | 77 | 9 | int:ZNF330 | |
| Interaction | KLHL40 interactions | 7.64e-05 | 59 | 77 | 4 | int:KLHL40 | |
| Interaction | RPL30 interactions | 7.98e-05 | 474 | 77 | 9 | int:RPL30 | |
| Interaction | CLK2 interactions | 1.02e-04 | 195 | 77 | 6 | int:CLK2 | |
| Interaction | ZNF787 interactions | 1.05e-04 | 64 | 77 | 4 | int:ZNF787 | |
| Interaction | FBLN2 interactions | 1.19e-04 | 66 | 77 | 4 | int:FBLN2 | |
| Interaction | TRIM28 interactions | ZNF490 ZNF10 ZNF627 ZNF182 OGT ZNF555 HLA-B ZNF792 HMGB1 ZNF350 ZNF81 ZNF841 ARIH1 ZBTB11 ZNF169 ZNF557 | 1.19e-04 | 1474 | 77 | 16 | int:TRIM28 |
| Interaction | ZSCAN21 interactions | 1.31e-04 | 128 | 77 | 5 | int:ZSCAN21 | |
| Interaction | HCFC1R1 interactions | 1.43e-04 | 5 | 77 | 2 | int:HCFC1R1 | |
| Interaction | KRTAP10-8 interactions | 1.45e-04 | 401 | 77 | 8 | int:KRTAP10-8 | |
| Interaction | ZNF423 interactions | 1.76e-04 | 73 | 77 | 4 | int:ZNF423 | |
| Interaction | ZNF836 interactions | 2.14e-04 | 6 | 77 | 2 | int:ZNF836 | |
| Interaction | ZBTB47 interactions | 2.27e-04 | 144 | 77 | 5 | int:ZBTB47 | |
| Cytoband | 19p13.2 | 2.54e-06 | 229 | 77 | 6 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZSCAN5B ZNF836 ZNF792 ZNF780B ZNF837 ZNF350 ZNF772 ZNF841 SNRNP70 | 1.73e-04 | 1192 | 77 | 9 | chr19q13 |
| Cytoband | 7q36.1 | 2.70e-04 | 74 | 77 | 3 | 7q36.1 | |
| Cytoband | 16p11.2 | 3.10e-04 | 191 | 77 | 4 | 16p11.2 | |
| Cytoband | 19q13.41 | 3.15e-04 | 78 | 77 | 3 | 19q13.41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.88e-04 | 797 | 77 | 7 | chr19p13 | |
| Cytoband | 19q13.43 | 4.34e-04 | 87 | 77 | 3 | 19q13.43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 1.26e-03 | 278 | 77 | 4 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 2.47e-03 | 159 | 77 | 3 | chr7q36 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF490 ZNF10 BCL6B ZNF131 ZNF18 ZNF627 ZSCAN5B ZNF836 ZNF536 ZNF182 ZNF142 ZNF672 ZNF48 ZNF555 ZNF474 ZNF792 ZNF425 GLI2 MAZ ZNF780B ZNF837 ZNF500 ZNF629 ZNF69 ZSCAN2 ZNF350 ZNF81 ZNF772 ZNF841 ZBTB11 ZNF442 REPIN1 ZNF768 ZNF786 ZNF169 ZNF491 ZNF572 ZNF513 ZNF557 | 1.10e-40 | 718 | 59 | 39 | 28 |
| GeneFamily | C1-set domain containing | 8.29e-03 | 42 | 59 | 2 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 9.07e-03 | 44 | 59 | 2 | 588 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 9.56e-03 | 134 | 59 | 3 | 861 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 3.49e-05 | 3 | 73 | 2 | PCBC_ratio_ESC_vs_iPSC_method-OSK-L-l-p53KD_cfr-2X-p05 | |
| Disease | – | 4.93e-06 | 2 | 66 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 4.93e-06 | 2 | 66 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 4.93e-06 | 2 | 66 | 2 | cv:CN077964 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 2.95e-05 | 4 | 66 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.03e-04 | 7 | 66 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | dipeptidase 2 measurement | 2.19e-04 | 10 | 66 | 2 | EFO_0801528 | |
| Disease | Ankylosing spondylitis | 2.68e-04 | 11 | 66 | 2 | C0038013 | |
| Disease | beta-2 microglobulin measurement | 2.68e-04 | 11 | 66 | 2 | EFO_0005197 | |
| Disease | Tourette syndrome, schizophrenia | 7.37e-04 | 18 | 66 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | autism spectrum disorder, schizophrenia | 8.33e-04 | 327 | 66 | 5 | EFO_0003756, MONDO_0005090 | |
| Disease | Brain Diseases | 1.43e-03 | 25 | 66 | 2 | C0006111 | |
| Disease | visual perception measurement | 1.59e-03 | 223 | 66 | 4 | EFO_0009700 | |
| Disease | Encephalopathies | 1.67e-03 | 27 | 66 | 2 | C0085584 | |
| Disease | tuberculosis (is_implicated_in) | 1.79e-03 | 28 | 66 | 2 | DOID:399 (is_implicated_in) | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.92e-03 | 29 | 66 | 2 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 1.92e-03 | 29 | 66 | 2 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.92e-03 | 29 | 66 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.92e-03 | 29 | 66 | 2 | C3658302 | |
| Disease | Stevens-Johnson Syndrome | 2.06e-03 | 30 | 66 | 2 | C0038325 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EPHHCPLQKYTRLQT | 531 | Q2NKJ3 | |
| GRKQCKTHPHFVIPY | 101 | P05067 | |
| VLPKIHEDKHYPCTL | 96 | O75323 | |
| ERCHQKVYHPITKPG | 281 | Q08AF8 | |
| CHHVVKVQYPDAKPV | 281 | Q9Y4X5 | |
| RHPVCVKHPPSVKYA | 56 | P0C5J1 | |
| CSEYRPKIKGEHPGL | 106 | P09429 | |
| PYHLIKCRKNHPDVA | 31 | Q8WW33 | |
| RHPVCVKHPPSVKYA | 56 | Q8N7N1 | |
| EMCPEEYPHLKNHGL | 581 | P55160 | |
| RHKLSHSDEKPYQCP | 296 | P56270 | |
| RTHSNEKPYICKIPG | 556 | P10070 | |
| YKEKAPDCHGPVLKH | 366 | Q9Y546 | |
| YTCHVQHEGLPKPLT | 281 | P01889 | |
| HRLCPTHVYAAPEGK | 386 | P20393 | |
| PIGEVHKDDKPVNCH | 391 | P16615 | |
| ERCHQKVYHPITKPG | 281 | Q0D2H9 | |
| VRIHTGEKPYHCDPC | 431 | Q8N143 | |
| TRCPNPEVKHGYKLN | 786 | P20023 | |
| HYKQVLERLCKHHPP | 691 | Q9Y4F1 | |
| PRQDPHKAGLSHYVK | 451 | Q96BT3 | |
| LYPKCTDHRVIPQHQ | 1241 | O60503 | |
| YTCHVQHEGLPKPLT | 281 | P04439 | |
| KKHGFDPQSPLCVHI | 136 | O75629 | |
| IPHQHRFTPEKYACK | 311 | P26927 | |
| CLDKINVLHKPPYEH | 531 | O15294 | |
| QLYHKCTHKGRPGPQ | 56 | P00748 | |
| EKLPHEKHHNQPYCG | 26 | P08621 | |
| FGPHKVAPVKVHQYD | 76 | Q8IYX7 | |
| YPGFPKVTEVHHEQK | 221 | O76064 | |
| HGPYDCNQPHRKTKI | 146 | B4DH59 | |
| HIGHPYPTEDEKKQI | 281 | P55347 | |
| IHHAAQGPRKKYPET | 71 | A6NL82 | |
| IHCHPKYGIDPEDTK | 1821 | Q9NTG1 | |
| DGNYFEHKHNIRPKP | 111 | Q53GG5 | |
| SHRRIHTGEKPYPCK | 281 | Q9BWE0 | |
| HRRVHTGEKPYACPE | 381 | Q96EG3 | |
| HERTHTGEKPYKCPE | 206 | Q7Z3I7 | |
| EHQRTHTGEKPYKCP | 261 | Q7Z3I7 | |
| HQRVHTGEKPYKCPL | 406 | Q8N8E2 | |
| KHQPKPEVRGYHCTQ | 756 | O95625 | |
| IHQRIHTGEKPYECP | 531 | P17025 | |
| HLRVHTGEKPYLCPE | 321 | Q96MX3 | |
| HTTEKQYKCNVGHPP | 586 | Q8NEP9 | |
| HQRIHTGEKPYKCPE | 576 | Q7Z7L9 | |
| QKPNECHEYGEKPHK | 181 | Q9ULM2 | |
| VHQRTHSGEKPYKCP | 456 | A6NJL1 | |
| RHLQTHSGEKPFKCP | 216 | Q499Z4 | |
| KHQRTHTGERPYKCP | 306 | Q9H5H4 | |
| QRTHSGQKPYKCPHC | 336 | Q9H5H4 | |
| KPDHDPNTRHCLYGL | 191 | Q8IZH2 | |
| VHEKIHTGEKPYENP | 436 | Q7L945 | |
| PYKPHPHDLVGKDCR | 71 | Q04864 | |
| HEENFSVRCPKHKPP | 1921 | Q9UGU0 | |
| SPIHNTHKPYECKEC | 156 | Q9Y6R6 | |
| SHKPLYLKHVCQPGR | 506 | Q8NF64 | |
| EHQRTHTGEKPYECP | 251 | Q9GZX5 | |
| RIHTGEKPYKCPHCD | 771 | O15090 | |
| ARYHRNPTGEKPHKC | 581 | Q6ZN19 | |
| RHQRTHTGEKPYECP | 366 | P21506 | |
| HIRTHTGEKPFQCPK | 666 | Q8N393 | |
| KPDECQEYGEKPHTH | 141 | Q9H7R0 | |
| QHLKVHKPDRPYECS | 551 | Q3KQV3 | |
| MHGRTHPEDKPYECK | 551 | Q9UC07 | |
| GHQPHKCQKFLEKPY | 61 | Q8N8L2 | |
| VHQRSCKTHPYGPKY | 301 | Q6S9Z5 | |
| HHEKIHTGEKPYKCP | 481 | P17022 | |
| HLRKHTGEKPFECPN | 346 | P52739 | |
| HKCKYYHPERGSQPQ | 426 | Q9C0D7 | |
| HMTKHTGLKPYQCPE | 1526 | P52746 | |
| PPDGCNAFVVIHKKH | 131 | Q9NYU1 | |
| HQRTHTGEKPYKCPD | 196 | Q9UEG4 | |
| HRRTHTGEKPYKCPE | 476 | Q9UEG4 | |
| PHLRIHTGEKPYKCN | 246 | Q8N988 | |
| HIRVHSGEKPFQCPE | 656 | Q6IV72 | |
| ERAYAKPPSHHVKAG | 441 | A7MCY6 | |
| EHQETHPGQKPYMCV | 161 | Q68DY9 | |
| KHQRTHTGEKPYLCP | 251 | Q14929 | |
| HQRTHTGEKPYLCPK | 476 | Q14929 | |
| RYHRNPTGEKPHKCS | 711 | Q6ZNA1 | |
| THQRIHTTEKPYKCP | 571 | P51508 | |
| HQRVHTGEKPYPCPE | 371 | O60304 | |
| YRLPGDTPHFKHIKD | 4961 | P20929 |